Boston Partners Viatris Inc Transaction History

Boston Partners

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $3.47 Million - $4.56 Million	-409,706 Reduced 85.24%	70,922 $604,000
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $287,296 - $354,283	28,874 Added 6.39%	480,628 $5.03 Million
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $342,673 - $537,937	-34,931 Reduced 7.18%	451,754 $4.92 Million
Q4 2021 Feb 04, 2022	SELL	$12.09 - $14.68 $1.22 Million - $1.48 Million	-100,941 Reduced 17.18%	486,685 $6.59 Million
Q3 2021 Nov 05, 2021	SELL	$13.25 - $15.13 $96,937 - $110,691	-7,316 Reduced 1.23%	587,626 $7.96 Million
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $167,053 - $208,011	12,880 Added 2.21%	594,942 $8.5 Million
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $66.6 Million - $90.8 Million	-4,899,078 Reduced 89.38%	582,062 $8.13 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $75.1 Million - $98.5 Million	5,255,167 Added 2325.57%	5,481,140 $103 Million
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $3.23 Million - $4.23 Million	225,973 New	225,973 $4.23 Million

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.